NCT00000334 is a Phase 2 clinical trial of Buprenorphine in Opioid-Related Disorders, sponsored by National Institute on Drug Abuse (NIDA).

Who is sponsoring NCT00000334?

NCT00000334 is sponsored by National Institute on Drug Abuse (NIDA).

What drugs are being tested in NCT00000334?

Interventions in NCT00000334: Buprenorphine.

What condition does NCT00000334 study?

NCT00000334 studies Opioid-Related Disorders.

Is NCT00000334 still recruiting?

NCT00000334 is currently completed. Last updated 31 January 2017.

Last reviewed 2017-01-31 · How we verify

NCT00000334

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Buprenorphine and Methadone - 3

Completed Phase 2 Last updated 31 January 2017

What this trial tests

Phase 2 trial testing Buprenorphine in Opioid-Related Disorders. Completed in 15 January 2005.

Timeline

1 December 2002

Primary endpoint
1 November 2004

15 January 2005

Quick facts

Lead sponsor	National Institute on Drug Abuse (NIDA)
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Primary purpose	treatment
Start date	1 December 2002
Primary completion	1 November 2004
Estimated completion	15 January 2005
Sites	1 location across United States

Drugs / interventions tested

Buprenorphine (BUPRENORPHINE) — full drug profile →

Conditions studied

Opioid-Related Disorders — all drugs for Opioid-Related Disorders →

Sponsor

National Institute on Drug Abuse (NIDA)

Who can join

Adults 23 to 45, male only, with Opioid-Related Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare agonist and antagonist profile associated with buprenorphine vs. methadone during opiate withdrawal.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Buprenorphine

Trials testing the same drug.

NCT06379984 — Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use · Phase 2 · recruiting
NCT06316830 — Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose · Phase 2, PHASE3 · recruiting
NCT06086275 — Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder · Phase 1 · completed
NCT06406400 — Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics o · Phase 1 · terminated
NCT06008990 — Maternal Brain Imaging in Opioid Use Disorder · active not recruiting

Other recruiting trials for Opioid-Related Disorders

Currently open trials in the same condition.

NCT06810076 — Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care · NA · active not recruiting
NCT06454903 — Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment · NA · recruiting
NCT06387290 — Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits · Phase 3 · recruiting
NCT06023459 — Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) · Phase 3 · active not recruiting
NCT06001749 — Psilocybin in Cancer Pain Study · Phase 2 · recruiting

Other National Institute on Drug Abuse (NIDA) trials

Trials by the same sponsor.

NCT07468552 — Trial of Tirzepatide for the Treatment of Cannabis Use Disorder · Phase 2 · not yet recruiting
NCT06808932 — VK4-116 Phase I Study With Food-Effect · Phase 1 · not yet recruiting
NCT06676059 — SMART-r: Substance Monitoring and Active Relapse Tracking Repository · recruiting
NCT06577454 — Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Sub · NA · suspended
NCT06868914 — Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00000334 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Institute on Drug Abuse (NIDA)
Last refreshed: 31 January 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00000334.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing